v3.26.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Assets and Liabilities Measured at Fair Value on Recurring Basis The following tables present the fair value of assets and liabilities measured at fair value on a recurring basis as of
September 30, 2026 and December 31, 2025 (dollars in millions):
As of September 30, 2026
Fair Value Measured and Recorded Using
Level 1
Level 2
Level 3
Total
Assets
Available for sale debt securities:
U.S. treasury securities
$6
$—
$—
$6
Corporate debt securities
—
36
—
36
Asset-backed securities
—
6
—
6
Total available for sale debt securities
6
42
—
48
Equity securities
20
—
—
20
Investments in unconsolidated subsidiaries
—
—
19
19
Warehouse receivables
—
945
—
945
Derivative assets
—
95
—
95
Total assets at fair value
$26
$1,082
$19
$1,127
Liabilities
Contingent consideration
—
—
24
24
Derivative liabilities
—
361
—
361
Total liabilities at fair value
$—
$361
$24
$385
As of December 31, 2025
Fair Value Measured and Recorded Using
Level 1
Level 2
Level 3
Total
Assets
Available for sale debt securities:
U.S. treasury securities
$4
$—
$—
$4
Corporate debt securities
—
36
—
36
Asset-backed securities
—
7
—
7
Total available for sale debt securities
4
43
—
47
Equity securities
19
—
—
19
Investments in unconsolidated subsidiaries
—
—
19
19
Warehouse receivables
—
1,630
—
1,630
Derivative assets
—
63
—
63
Total assets at fair value
$23
$1,736
$19
$1,778
Liabilities
Contingent consideration
—
—
65
65
Derivative liabilities
—
292
—
292
Total liabilities at fair value
$—
$292
$65
$357
Schedule of Reconciliation for Assets Measured at Fair Value The tables below present a reconciliation for assets and liabilities measured at fair value on a recurring basis using
significant unobservable inputs (Level 3) (dollars in millions):
Investment in
Unconsolidated
Subsidiaries
Contingent
Consideration (1)
Balance as of June 30, 2026
$19
$34
Net change in fair value
—
(4)
Sales / Payments
—
(6)
Balance as of September 30, 2026
$19
$24
Balance as of December 31, 2025
$19
$65
Net change in fair value
—
(23)
Sales / Payments
—
(18)
Balance as of September 30, 2026
$19
$24
________________________________________________________________________________________________________________________________________
(1)As of September 30, 2026, a Monte Carlo model was used to estimate the fair value of Contingent Consideration related to the Pearce acquisition. The
unobservable inputs used for volatility and the discount rate were 17.6% and 4.9%, respectively.
Net change in fair value, included in the table above, is reported in Net income as follows:
Category of Assets/Liabilities using Unobservable Inputs
Consolidated Financial Statements
Investments in unconsolidated subsidiaries
Equity income from unconsolidated subsidiaries
Contingent consideration
Operating, administrative and other
Schedule of Reconciliation for Liabilities Measured at Fair Value The tables below present a reconciliation for assets and liabilities measured at fair value on a recurring basis using
significant unobservable inputs (Level 3) (dollars in millions):
Investment in
Unconsolidated
Subsidiaries
Contingent
Consideration (1)
Balance as of June 30, 2026
$19
$34
Net change in fair value
—
(4)
Sales / Payments
—
(6)
Balance as of September 30, 2026
$19
$24
Balance as of December 31, 2025
$19
$65
Net change in fair value
—
(23)
Sales / Payments
—
(18)
Balance as of September 30, 2026
$19
$24
________________________________________________________________________________________________________________________________________
(1)As of September 30, 2026, a Monte Carlo model was used to estimate the fair value of Contingent Consideration related to the Pearce acquisition. The
unobservable inputs used for volatility and the discount rate were 17.6% and 4.9%, respectively.
Net change in fair value, included in the table above, is reported in Net income as follows:
Category of Assets/Liabilities using Unobservable Inputs
Consolidated Financial Statements
Investments in unconsolidated subsidiaries
Equity income from unconsolidated subsidiaries
Contingent consideration
Operating, administrative and other
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments
Estimated Fair Value
Carrying Value
Financial instrument
September 30, 2026
December 31, 2025
September 30, 2026
December 31, 2025
Senior term loans due 2028
$1,197
$1,239
$1,240
$1,322
5.500% senior notes due 2029
499
519
497
496
4.800% senior notes due 2030
582
608
592
591
2.500% senior notes due 2031
436
454
494
493
4.900% senior notes due 2033
702
755
743
742
5.950% senior notes due 2034
981
1,068
979
977
5.500% senior notes due 2035
473
516
494
494
5.250% senior notes due 2036
692
—
735
—